NASDAQ:SCNX Scienture (SCNX) Stock Price, News & Analysis $8.15 +0.75 (+10.14%) (As of 12:01 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsTrends About Scienture Stock (NASDAQ:SCNX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Scienture alerts:Sign Up Key Stats Today's Range$7.22▼$8.3950-Day Range N/A52-Week Range$3.69▼$44.56Volume26,041 shsAverage Volume183,233 shsMarket Capitalization$14.26 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewTRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.Read More… This is treason (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Receive SCNX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Scienture and its competitors with MarketBeat's FREE daily newsletter. Email Address SCNX Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com SCNX Stock Analysis - Frequently Asked Questions How have SCNX shares performed this year? Scienture's stock was trading at $7.46 on January 1st, 2024. Since then, SCNX shares have decreased by 0.8% and is now trading at $7.40. View the best growth stocks for 2024 here. How were Scienture's earnings last quarter? Scienture Holdings, Inc. (NASDAQ:SCNX) posted its quarterly earnings results on Friday, August, 9th. The company reported ($1.04) earnings per share (EPS) for the quarter. The company had revenue of $0.02 million for the quarter. How do I buy shares of Scienture? Shares of SCNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Scienture own? Based on aggregate information from My MarketBeat watchlists, some other companies that Scienture investors own include Cogent Communications (CCOI), Cavco Industries (CVCO), Liberty Broadband (LBRDK), Liberty Global (LBTYB), PayPal (PYPL), Roku (ROKU) and Arch Capital Group (ACGL). Company Calendar Last Earnings8/09/2024Today10/28/2024Fiscal Year End12/31/2024Next Earnings (Estimated)1/21/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drugs, proprietaries, & sundries Sub-IndustryN/A Current SymbolNASDAQ:SCNX CUSIPN/A CIK1382574 Webwww.trxadehealth.com Phone(800) 261-0281Fax800-265-6932EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-17,840,000.00 Net MarginsN/A Pretax Margin-250.54% Return on Equity-198.55% Return on Assets-113.22% Debt Debt-to-Equity RatioN/A Current Ratio4.18 Quick Ratio4.18 Sales & Book Value Annual Sales$8.27 million Price / Sales1.57 Cash FlowN/A Price / Cash FlowN/A Book Value$0.45 per share Price / Book16.44Miscellaneous Outstanding Shares1,750,000Free Float1,241,000Market Cap$12.95 million OptionableN/A Beta2.30 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report This page (NASDAQ:SCNX) was last updated on 10/28/2024 by MarketBeat.com Staff From Our PartnersInvest in the company that won over the DragonsThe pioneer in smart-doorbell technology, RING, pitched their business on the hit show Shark Tank at a valuati...RYSE | SponsoredCountdown to Chaos begins WednesdayWill it be Trump or Harris? In an exclusive interview on Wednesday, October 30, at 8 p.m. ET, he’ll explain...Brownstone Research | SponsoredYour Money is Not SafeThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredThe secret supplier behind NVIDIA, Tesla and MicrosoftThe Biggest AI firms in the world...Tesla... Microsoft... NVIDIA... Are all relying on a little-known suppl...Behind the Markets | SponsoredAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.Monument Traders Alliance | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scienture Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Scienture With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.